Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agios Pharmaceuticals (AGIO) Current Deferred Tax Assets: 2012-2013

  • Agios Pharmaceuticals' Current Deferred Tax Assets was N/A to $1.2 million in Q3 2013 from the same period last year, while for Sep 2013 it was $1.2 million, marking a year-over-year change of. This contributed to the annual value of $1.2 million for FY2012, which is N/A change from last year.
  • Latest data reveals that Agios Pharmaceuticals reported Current Deferred Tax Assets of $1.2 million as of Q3 2013, which was down 0.08% from $1.2 million recorded in Q2 2013.
  • Agios Pharmaceuticals' Current Deferred Tax Assets' 5-year high stood at $1.2 million during Q2 2013, with a 5-year trough of $1.2 million in Q4 2012.
  • Moreover, its 2-year median value for Current Deferred Tax Assets was $1.2 million (2013), whereas its average is $1.2 million.